A weak activity of SSR-armed CLL1.CAR T cells was detected against CD38 bright NK cells, but it did not reach statistical significance, unlike in control CD38.CAR T cells (Fig. 5B, C and Supplementary Fig. 11C ).
← all excerpts
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor.
1
—
—